ELI-002 7P treatment during the Phase 2 AMPLIFY-7P study and received nivolumab-based subsequent therapy Complete responses (“CRs”) are rarely (0-8%) observed in metastatic pancreatic cancer in ...
Recent Publication and Growing Industry Focus on Immune-Priming Strategies Support Continued Evaluation of Gedeptin(R) as a ...
Please provide your email address to receive an email when new articles are posted on . Adding immune checkpoint inhibitors to neoadjuvant chemotherapy benefited certain patients with early-stage ...
Real-world analysis of adverse events associated with KIMMTRAK in metastatic uveal melanoma using the FAERS database. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...
Checkpoint inhibitors are a groundbreaking class of cancer treatment, but they come with two frustrating challenges. In some cases, tumors show no initial response, rendering the therapy ineffective ...
Checkpoint inhibitor-based therapy and ISRT may replace autologous transplant and high-dose chemotherapy in low-risk relapsed cHL, reducing side effects while maintaining EFS outcomes. The CheckMate ...
A multinational collaboration co-led by the Garvan Institute of Medical Research has uncovered a potential explanation for why some cancer patients receiving a type of immunotherapy called checkpoint ...
Analysis of 20 Independently Performed Assays to Measure Homologous Recombination Deficiency (HRD) in Ovarian Cancer: Findings From the Friends' HRD Harmonization Project This retrospective study used ...
Immune checkpoint inhibitors (ICIs) have transformed oncology by unleashing T cell–mediated antitumour responses through blockade of regulatory receptors such as CTLA-4 and PD-1. However, by ...
Please provide your email address to receive an email when new articles are posted on . Patients who received PD-1 or PD-L1 agents exhibited increased risk for psoriasis. Medical professionals should ...
USA: A matched-cohort study found that patients with lung cancer, melanoma, or kidney cancer who received PCSK9 inhibitors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results